CN102628763A - Reagent for high-efficiency elution of active antibodies in mouth swab and corresponding elution method - Google Patents
Reagent for high-efficiency elution of active antibodies in mouth swab and corresponding elution method Download PDFInfo
- Publication number
- CN102628763A CN102628763A CN2012100651906A CN201210065190A CN102628763A CN 102628763 A CN102628763 A CN 102628763A CN 2012100651906 A CN2012100651906 A CN 2012100651906A CN 201210065190 A CN201210065190 A CN 201210065190A CN 102628763 A CN102628763 A CN 102628763A
- Authority
- CN
- China
- Prior art keywords
- elution
- active antibodies
- solution
- prescription
- reagent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Abstract
The invention discloses a reagent for high-efficiency elution of active antibodies in a mouth swab and a corresponding elution method. The reagent comprises 8g/L of NaCl, 0.2g/L of KCl, 1.15g/L of Na2HPO4, 0.2g/L of KH2PO4, 0.05ml/L of Tween-20, 1g/L of bovine serum albumin (BSA), 0.2g/L of NaN3 and 100 micrograms per milliliter of goat anti-mouse IgG antibodies. Aiming at a mouth swab, the reagent for high-efficiency elution of active antibodies in a mouth swab and the corresponding elution method overcome the defects of the prior art.
Description
Technical field
The present invention relates to antibody and gather inspection technology, specifically a kind of reagent and elution process that is used for high-level efficiency wash-out buccal swab active antibodies.
Background technology
The mucous membrane of mouth transudate is the important development direction of present immune detection, carried out adopting mostly in the process of antibody test serum as detected object in the past, and its gatherer process causes wound, is not suitable for person under inspection's self check and has also strengthened person under inspection's misery simultaneously.In recent years; Detection to the mucous membrane of mouth transudate is growing; But the AC in the mucous membrane of mouth transudate is lower, particularly carries out can producing a large amount of losses in the process of antibody elution at swab, and it is mainly derived from two aspects; One, the improper antibody that makes of composition is adsorbed on the swab in a large number in the damping fluid, and two, the composition in the solution reduces the activity of antibody.If can being arranged, the method for active antibodies in the high-level efficiency wash-out buccal swab will greatly quicken antibody scope and sensitivity that the mucous membrane of mouth transudate detects.
Summary of the invention
To buccal swab, the present invention has overcome shortcoming of the prior art, and the agent prescription and the method for active antibodies in a kind of high-level efficiency wash-out buccal swab is provided.
In order to solve the problems of the technologies described above, the technical scheme that the present invention adopts is: configuration solution A and solution B also taked following method wash-out.
Wherein the prescription of solution A is NaCl 8g/L, KCl 0.2g/L, Na
2HPO
41.15g/L, KH
2PO
40.2g/L, tween (tween) 20 0.05ml/L, bovine serum albumin(BSA) (BSA) 1g/L, NaN
30.2g/L;
The prescription of solution B is that the prescription of B liquid is 100 μ g/mL sheep anti-mouse igg antibody solution.
Operated to be called earlier that buccal swab was infiltrated in the 2mL A liquid 10 minutes, and added 1mL B liquid again, buccal swab is fully concussion in above-mentioned solution, and the solution that the concussion back is obtained is active antibodies solution in the wash-out buccal swab.
Above-mentioned active antibodies solution end user immunoglobulin (Ig) (IgG) ELISA detection kit is carried out quantitative test, and analysis result is not with using the swab eluent of this method to compare, and this method of comparative result proof can improve 5 to 10 times of elution efficiencies.
Detection method is following:
Get mucous membrane of mouth transudate antibody sample of gathering according to prescription of the present invention and method and each the 100 μ L of mucous membrane of mouth transudate antibody sample that gather according to conventional method respectively.
In refrigerator, take out human immunoglobulin(HIg) (IgG) ELISA detection kit, take out required lath at room temperature in the aluminium foil bag behind the balance 20min, the residue lath is put back to 4 ℃ with the valve bag sealing.
Set up standard article hole and sample aperture, the standard items hole respectively adds the standard items 50 μ L of variable concentrations;
Sample aperture adds sample to be tested 10 μ L earlier, adds sample dilution 40 μ L again; Blank well does not add.
Except that blank well, every hole adds the detection antibody 100 μ L of horseradish peroxidase (HRP) mark in standard items hole and the sample aperture, seals reacting hole with the shrouding film, 37 ℃ of water-baths or constant temperature oven incubation 60min.
Discard liquid, the thieving paper arsis is done, and cleansing solution is filled it up with in every hole, leaves standstill 1min, gets rid of cleansing solution, and the thieving paper arsis is done, and so repeats to wash plate 5 times (the also available plate machine washing plate of washing).
Every hole adds substrate A, each 50 μ L of B, and 37 ℃ of lucifuges are hatched 15min.
Every hole adds stop buffer 50 μ L, in the 15min, measures the OD value in each hole in the 450nm wavelength.
The result judges
The drawing standard curve in the Excel worksheet, is made horizontal ordinate with standard items concentration, and corresponding OD value is made ordinate, draws out standard items linear regression curve, presses curvilinear equation and calculates each sample concentration value.
Above-mentioned antibody sample is analyzed, and analysis result is following:
Table one uses the present invention and does not use the AC in the sample that obtains of the present invention
Unit (10
2μ g/mL)
Do not use the present invention | Use the present invention | |
1 | 1.36 | 33.2 |
2 | 2.36 | 35.7 |
3 | 5.97 | 28.9 |
Description of drawings
Fig. 1 uses the present invention and does not use the AC in the sample that obtains of the present invention.
Embodiment
Below in conjunction with accompanying drawing and embodiment the present invention is done further explain:
The present invention realizes through following technical scheme:
(1) configuration solution A and solution B.
Wherein the prescription of solution A is NaCl 8g/L, KCl 0.2g/L, Na
2HPO
41.15g/L, KH
2PO
40.2g/L, tween (tween) 20 0.05ml/L, bovine serum albumin(BSA) (BSA) 1g/L, NaN3 0.2g/L;
The prescription of solution B is that the prescription of B liquid is 100 μ g/mL sheep anti-mouse igg antibody solution.
(2) swab of the mucous membrane of mouth transudate of gathering is put into the container that a volume is fit to.
(3) earlier buccal swab was infiltrated in the 2mL A liquid 10 minutes.
(4) add 1mL B liquid again, buccal swab is fully concussion in above-mentioned solution, and the solution that the concussion back is obtained is active antibodies solution in the wash-out buccal swab.
(5) above-mentioned sample solution is detected.
(6) in refrigerator, take out human immunoglobulin(HIg) (IgG) ELISA detection kit, take out required lath at room temperature in the aluminium foil bag behind the balance 20min.
(7) set up standard article hole and sample aperture, the standard items hole respectively adds the standard items 50 μ L of variable concentrations;
Sample aperture adds sample to be tested 10 μ L earlier, adds sample dilution 40 μ L again; Blank well does not add.
(8) except that blank well, every hole adds the detection antibody 100 μ L of horseradish peroxidase (HRP) mark in standard items hole and the sample aperture, seals reacting hole with the shrouding film, 37 ℃ of water-baths or constant temperature oven incubation 60min.
(9) discard liquid, the thieving paper arsis is done, and cleansing solution is filled it up with in every hole, leaves standstill 1min, gets rid of cleansing solution, and the thieving paper arsis is done, and so repeats to wash plate 5 times (the also available plate machine washing plate of washing).
(10) every hole adds substrate A, each 50 μ L of B, and 37 ℃ of lucifuges are hatched 15min.
(11) every hole adds stop buffer 50 μ L, in the 15min, measures the OD value in each hole in the 450nm wavelength.
(12) drawing standard curve in the Excel worksheet, is made horizontal ordinate with standard items concentration, and corresponding OD value is made ordinate, draws out standard items linear regression curve, presses curvilinear equation and calculates each sample concentration value.
The AC that uses this method to gather after measured is 3.1mg/mL.Near the antibody content in the serum.
Claims (2)
1. an agent prescription that is used for high-level efficiency wash-out buccal swab active antibodies comprises a plurality of components in its prescription, comprises NaCl 8g/L, KCl 0.2g/L, Na
2HPO
41.15g/L, KH
2PO
40.2g/L, tween (tween) 20 0.05ml/L, bovine serum albumin(BSA) (BSA) 1g/L, NaN
30.2g/L and 100 μ g/mL sheep anti-mouse igg antibodies.
2. a kind of agent prescription that is used for high-level efficiency wash-out buccal swab active antibodies according to claim 1 is characterised in that the elution step of buccal swab is following:
Earlier buccal swab was infiltrated in the 2mL A liquid 10 minutes, the prescription of A liquid is NaCl 8g/L, KCl0.2g/L, Na
2HPO
41.15g/L, KH
2PO
40.2g/L, tween (tween) 20 0.05ml/L, bovine serum albumin(BSA) (BSA) 1g/L, NaN
30.2g/L.
Add 1mL B liquid again, the prescription of B liquid is 100 μ g/mL sheep anti-mouse igg antibodies, and above-mentioned solution fully shakes, and the solution that the concussion back is obtained is active antibodies solution in the wash-out buccal swab.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100651906A CN102628763A (en) | 2012-03-14 | 2012-03-14 | Reagent for high-efficiency elution of active antibodies in mouth swab and corresponding elution method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012100651906A CN102628763A (en) | 2012-03-14 | 2012-03-14 | Reagent for high-efficiency elution of active antibodies in mouth swab and corresponding elution method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102628763A true CN102628763A (en) | 2012-08-08 |
Family
ID=46587062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012100651906A Pending CN102628763A (en) | 2012-03-14 | 2012-03-14 | Reagent for high-efficiency elution of active antibodies in mouth swab and corresponding elution method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102628763A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113884358A (en) * | 2021-10-09 | 2022-01-04 | 壹生检康(杭州)生命科技有限公司 | Preparation method of dried blood tablets |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1164278A (en) * | 1994-11-15 | 1997-11-05 | 科特克斯有限公司 | Analytical method for saliva |
CN101274963A (en) * | 2008-03-07 | 2008-10-01 | 卢小兵 | Anti-CD86 humanized monoclonal antibody |
-
2012
- 2012-03-14 CN CN2012100651906A patent/CN102628763A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1164278A (en) * | 1994-11-15 | 1997-11-05 | 科特克斯有限公司 | Analytical method for saliva |
CN101274963A (en) * | 2008-03-07 | 2008-10-01 | 卢小兵 | Anti-CD86 humanized monoclonal antibody |
Non-Patent Citations (2)
Title |
---|
KENICHIRO SHIBATA, ET AL: "用PCR 检测人唾液中的发酵支原体", 《医学信息》 * |
陈昌荣等: "唾液分泌型免疫球蛋白A 对口腔白假丝酵母菌黏附的影响", 《国际口腔医学杂志》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113884358A (en) * | 2021-10-09 | 2022-01-04 | 壹生检康(杭州)生命科技有限公司 | Preparation method of dried blood tablets |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102520195B (en) | Chromogranin A chemiluminescence immunoassay reagent kit and preparation method thereof | |
Qian et al. | High temperatures enhanced acute mortality effects of ambient particle pollution in the “oven” city of Wuhan, China | |
CN201965131U (en) | Quick test paper of hepatitis A virus (HAV) IgM antibody | |
CN107340386A (en) | SST2 detection kits based on microparticle chemiluminescence immunoassay | |
CN103901203A (en) | Chemiluminescence quantitative detection kit for procalcitonin, and preparation method and detection method thereof | |
WO2014153099A3 (en) | Method for using exhaled breath to determine the presence of drug | |
CN106645729A (en) | Chemiluminescent kit for quantitatively detecting mycobacterium tuberculosis r interferon as well as preparation method, detection method and evaluation method of chemiluminescent kit | |
Bansal et al. | Deficiencies of serum ferritin and vitamin B | |
CN104678103A (en) | Chemical luminescent protein chip, kit and detection method for detecting fucose index of seroglycoid | |
RU2013105265A (en) | DIAGNOSTIC METHOD FOR Pancreatic Cancer | |
CN101231291A (en) | Kit and method for quantitative determination of Fumonisin B1 content in food by ELISA detection technique | |
CN102628763A (en) | Reagent for high-efficiency elution of active antibodies in mouth swab and corresponding elution method | |
Tabrizi et al. | Health consequences of Lake Urmia in crisis in the disaster area: a pilot study | |
Rodríguez et al. | 9 Relationship Between Airborne Pollen Counts and the Results Obtained Using 2 Diagnostic Methods: Allergen-Specific Immunoglobulin E Concentrations and Skin Prick Tests | |
CN102128937B (en) | Evaluating and monitoring method for effect of desensitization therapy, detection kit of allergen specificity IgG4 antibody and preparation method thereof | |
CN102749456A (en) | Kit for chemilumineseent quantitative immunoassay of angiotensin I and preparation method thereof | |
EP3640644A1 (en) | Target marker gp73 for detecting steatohepatitis and detection application method | |
CN102590517A (en) | Immunochromatography test paper and preparation method thereof | |
CN104569390A (en) | Quantitative detection method for gamma-interferon and kit | |
CN101788562A (en) | Influenza A (H1N1) virus total antibody rapid detection test paper | |
CN103513036A (en) | CLEIA detection kit and detection method of salmonella | |
CN102735679B (en) | Kit for aldosterone chemiluminescence immunization quantitative determination and its preparation method | |
CN103226146B (en) | The detection method of the three-in-one euzymelinked immunosorbent assay (ELISA) of Clenbuterol, Ractopamine, salbutamol and dedicated kit and kit | |
Dronda et al. | Response to HAART in treatment-naive HIV-infected patients with a prior diagnosis of tuberculosis or other opportunistic infections | |
CN103901202B (en) | Based on the universal competitive ELISA detection method of total epi-position influenza A virus antibody |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120808 |